The Tumor Pathology of Genetically Engineered Mice: A New Approach to Molecular Pathology
暂无分享,去创建一个
[1] neurocirujo. Endocrine system the pituitary gland. , 2007, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[2] Therese Sørlie,et al. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. , 2004, European Journal of Cancer.
[3] S. Lowe,et al. Intrinsic tumour suppression , 2004, Nature.
[4] Christopher H. Contag,et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.
[5] R. Cardiff. Pathology of Mouse Models of Cancer , 2004 .
[6] M. Clarke,et al. Self-renewal and solid tumor stem cells , 2004, Oncogene.
[7] L. Harrington. Does the reservoir for self-renewal stem from the ends? , 2004, Oncogene.
[8] J. Dick,et al. Concepts of human leukemic development , 2004, Oncogene.
[9] J. Gregg,et al. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. , 2004, Molecular cancer research : MCR.
[10] W. Muller,et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.
[11] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[12] S. Cramer. Diagnostic accuracy of second-opinion diagnoses based on still images. , 2004, Human pathology.
[13] R. Cardiff,et al. Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin‐RAS transgenic mice , 2004, The Prostate.
[14] Jose J. Galvez,et al. Mouse models of human cancers (part 3). , 2004, Comparative medicine.
[15] S. Hilsenbeck,et al. Somatic Mutation of p53 Leads to Estrogen Receptor α-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis , 2004, Cancer Research.
[16] K. Jain,et al. Applications of biochips: from diagnostics to personalized medicine. , 2004, Current opinion in drug discovery & development.
[17] Giovanni Parmigiani,et al. A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer , 2004, Clinical Cancer Research.
[18] E. Schmidt. The role of c-myc in regulation of translation initiation , 2004, Oncogene.
[19] R. Cardiff,et al. Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.
[20] Jules J Berman,et al. Tumor classification: molecular analysis meets Aristotle , 2004, BMC Cancer.
[21] M. Rubin,et al. Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.
[22] N. Greenberg,et al. Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype , 2004, Journal of cellular biochemistry.
[23] Jose J. Galvez,et al. Mouse models of human cancers (Part 2). , 2004, Comparative medicine.
[24] R. Cardiff,et al. Angiogenic Acceleration of Neu Induced Mammary Tumor Progression and Metastasis , 2004, Cancer Research.
[25] Jose J. Galvez,et al. Validation: The New Challenge for Pathology , 2004, Toxicologic pathology.
[26] H. Varmus,et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Sugimoto,et al. PI3K/Akt and apoptosis: size matters , 2003, Oncogene.
[28] R. Cardiff,et al. Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors , 2003, Molecular and Cellular Biology.
[29] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[30] José L. V. Mejino,et al. A reference ontology for biomedical informatics: the Foundational Model of Anatomy , 2003, J. Biomed. Informatics.
[31] J. Downing,et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. , 2003, Blood.
[32] A. Berns,et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.
[33] J. Minna,et al. A big step in the study of small cell lung cancer. , 2003, Cancer cell.
[34] R. Cardiff,et al. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. , 2003, Cancer research.
[35] Hiroki Nagase,et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human , 2003, Nature Genetics.
[36] R. Cardiff,et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. , 2003, Cancer research.
[37] K. Desai,et al. Interrogating Mouse Mammary Cancer Models: Insights from Gene Expression Profiling , 2003, Journal of Mammary Gland Biology and Neoplasia.
[38] R. Cardiff,et al. Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation , 2003, Oncogene.
[39] T. Dragani. 10 years of mouse cancer modifier loci: human relevance. , 2003, Cancer research.
[40] Todd R. Golub,et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] Jose J. Galvez,et al. Comparative pathology of mouse models of human cancers: Genetically engineering a mouse , 2003 .
[42] R. Cardiff. Mouse models of human breast cancer. , 2003, Comparative medicine.
[43] J. Arbeit. Mouse models of cervical cancer. , 2003, Comparative medicine.
[44] R. Cardiff,et al. Mouse strains for prostate tumorigenesis based on genes altered in human prostate cancer. , 2003, Current drug targets.
[45] K. Washington,et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.
[46] Robert D Cardiff,et al. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. , 2003, Genes & development.
[47] T. Mak,et al. Physiological functions of Pten in mouse tissues. , 2003, Cell structure and function.
[48] P. Chambon,et al. Expression of conditional cre recombinase in epithelial tissues of transgenic mice , 2003, Genesis.
[49] D. Tuveson,et al. In Search of an Early Warning System for Pancreatic Cancer , 2003, Cancer biology & therapy.
[50] R. Cardiff,et al. Validation of Transgenic Mammary Cancer Models: Goals of the NCI Mouse Models of Human Cancer Consortium and the Mammary Cancer CD-ROM , 2002, Transgenic Research.
[51] Mitchell D Schnall,et al. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. , 2002, Cancer cell.
[52] R. Cardiff,et al. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. , 2002, The American journal of pathology.
[53] Karlyne M. Reilly,et al. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum , 2002, Oncogene.
[54] Robert D Cardiff,et al. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. , 2002, The American journal of pathology.
[55] R. Cardiff,et al. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. , 2002, Cancer research.
[56] R. Cardiff,et al. Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors , 2002, Oncogene.
[57] Jose J. Galvez,et al. Prostatic intraepithelial neoplasia in genetically engineered mice. , 2002, The American journal of pathology.
[58] Thierry Soussi,et al. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. , 2002, Gastroenterology.
[59] N. Harris,et al. Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.
[60] J. Downing,et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. , 2002, Blood.
[61] T. Sugino,et al. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. , 2002, The American journal of pathology.
[62] R. Cardiff,et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. , 2002, Cancer research.
[63] S. Barthold. "Muromics": genomics from the perspective of the laboratory mouse. , 2002, Comparative medicine.
[64] F. Kittrell,et al. Biological and genetic properties of the p53 null preneoplastic mammary epithelium , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[65] Richard Simon,et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[66] Robert B Boxer,et al. A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] R. Cardiff,et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[68] J. Gregg,et al. Contributions of mouse biology to breast cancer research. , 2002, Comparative medicine.
[69] R. Cardiff,et al. Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[70] E. Gabrielson,et al. Functional Genomics, Gene Arrays, and the Future of Pathology , 2001, Modern Pathology.
[71] R. Cardiff,et al. Mammary Disease Mice Model Premalignant Polyoma Middle-T Transgenic Updated Version , 2001 .
[72] R. Cardiff,et al. Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice , 2001, Oncogene.
[73] R. Cardiff,et al. Mammary Cancer in Humans and Mice: A Tutorial for Comparative Pathology , 2001, Veterinary pathology.
[74] Y. Geng,et al. Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.
[75] L. Villarreal,et al. Natural Biology of Polyomavirus Middle T Antigen , 2001, Microbiology and Molecular Biology Reviews.
[76] R. Cardiff,et al. Protein kinase CK2 in mammary gland tumorigenesis , 2001, Oncogene.
[77] R. Cardiff,et al. Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. , 2001, Cancer research.
[78] P. Chaurand,et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. , 2001, Cancer research.
[79] M. Moran,et al. Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer , 2001, Molecular and Cellular Biology.
[80] R. Cardiff,et al. Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression , 2001, Molecular and Cellular Biology.
[81] J. Decaprio,et al. Cellular transformation by SV40 large T antigen: interaction with host proteins. , 2001, Seminars in cancer biology.
[82] R. Cardiff,et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations , 2001, Nature Medicine.
[83] R. Cardiff,et al. Validity of Mouse Mammary Tumour Models for Human Breast Cancer: Comparative Pathology , 2022 .
[84] R. Cardiff,et al. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. , 2000, Cancer research.
[85] Chen-feng Qi,et al. Burkitt Lymphoma in the Mouse , 2000, The Journal of experimental medicine.
[86] R. Cardiff,et al. Genetically Engineered Mouse Models of Mammary Intraepithelial Neoplasia , 2000, Journal of Mammary Gland Biology and Neoplasia.
[87] K. Hunter,et al. An epistatic interaction controls the latency of a transgene-induced mammary tumor , 2000, Mammalian Genome.
[88] E. Andrechek,et al. Tyrosine kinase signalling in breast cancer: Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer , 2000, Breast Cancer Research.
[89] R. Cardiff,et al. Mammary Cancer in Humans and Mice: A Tutorial for Comparative Pathology. The CD-ROM , 2000, Journal of Mammary Gland Biology and Neoplasia.
[90] M. Rudnicki,et al. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[91] R. Cardiff,et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.
[92] F. DeMayo,et al. MORPHOMETRIC ANALYSIS OF CC10-hASH1 TRANSGENIC MOUSE LUNG: A Model for Bronchiolization of Alveoli and Neuroendocrine Carcinoma , 2000, Experimental lung research.
[93] A. Balmain,et al. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[94] D. Hanahan,et al. Tumor Cells Utilize Multiple Pathways to Down‐modulate Apoptosis: Lessons from a Mouse Model of Islet Cell Carcinogenesis , 1999, Annals of the New York Academy of Sciences.
[95] Joel H. Saltz,et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. , 1999, Cancer research.
[96] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[97] P. Musiani,et al. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[98] R. Cardiff,et al. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. , 1999, Cancer research.
[99] D. Pinkel,et al. The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.
[100] Emmett V Schmidt,et al. The role of c-myc in cellular growth control , 1999, Oncogene.
[101] B. Foster,et al. Pathologic progression of autochthonous prostate cancer in the TRAMP model , 1999, Prostate Cancer and Prostatic Diseases.
[102] P. Humphrey,et al. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[103] J M Ward,et al. Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.
[104] R. Cardiff,et al. Active signaling by Neu in transgenic mice , 1998, Oncogene.
[105] A. Balmain,et al. Cancer resistance genes in mice: models for the study of tumour modifiers. , 1998, Trends in genetics : TIG.
[106] John N. Hutchinson,et al. Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.
[107] R. Matusik,et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[108] A. Thomson,et al. Enlargement of the ampullary gland and seminal vesicle, but not the prostate in int-2/Fgf-3 transgenic mice. , 1998, Differentiation; research in biological diversity.
[109] J. Green,et al. Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model. , 1998, International journal of oncology.
[110] R. Cardiff,et al. Differential expression of the neu transgene in murine mammary tissues. , 1997, International journal of oncology.
[111] G. Pinkus,et al. The development of a model for the homing of multiple myeloma cells to human bone marrow. , 1997, Blood.
[112] R. Cardiff,et al. Microcirculation and metastasis in a new mouse mammary tumor model system. , 1997, International journal of oncology.
[113] B. Li,et al. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice , 1997, Molecular and cellular biology.
[114] Bin Chen,et al. Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice. , 1997, Gene.
[115] R. Maronpot,et al. Spontaneous Lesions in Aging FVB/N Mice , 1996, Toxicologic pathology.
[116] R. Cardiff,et al. Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. , 1996, The American journal of pathology.
[117] J. Rosen,et al. Metastatic prostate cancer in a transgenic mouse. , 1996, Cancer research.
[118] M. Leach,et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.
[119] R. Cardiff,et al. Activated neu Induces Rapid Tumor Progression (*) , 1996, The Journal of Biological Chemistry.
[120] R. Palmiter,et al. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. , 1995, Cancer research.
[121] R. Cardiff,et al. C-myc protein distribution - mammary adenocarcinomas of mtv/myc transgenic mice. , 1995, International journal of oncology.
[122] R. Nusse,et al. Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer. , 1995, Seminars in cancer biology.
[123] R. Matusik,et al. Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[124] C. MacArthur,et al. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis , 1995, Journal of virology.
[125] R. Cardiff,et al. Comparative pathology of mammary tumorigenesis in transgenic mice. , 1995, Cancer letters.
[126] P. Leder,et al. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[127] T. van Dyke,et al. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen , 1994, Molecular and cellular biology.
[128] G. Nicolson. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis , 1993, Cancer and Metastasis Reviews.
[129] R. Cardiff,et al. Multiple tumor types appear in a transgenic mouse with the ras oncogene. , 1993, The American journal of pathology.
[130] G. V. Vande Woude,et al. Mos and the cell cycle: the molecular basis of the transformed phenotype. , 1993, Current opinion in genetics & development.
[131] R. Cardiff,et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[132] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[133] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[134] R. Cardiff,et al. Transgenic oncogene mice. Tumor phenotype predicts genotype. , 1991, The American journal of pathology.
[135] M. Barbacid,et al. Activation of ras oncogenes preceding the onset of neoplasia. , 1990, Science.
[136] P. Leder,et al. Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. , 1989, The American journal of pathology.
[137] P. Jolicoeur,et al. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene , 1989, Cell.
[138] J. Vaage. A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors , 1989, International journal of cancer.
[139] H. Zerban,et al. Significance of Sequential Cellular Changes Inside and Outside Foci of Altered Hepatocytes During Hepatocarcinogenesis∗ , 1989, Toxicologic pathology.
[140] R. Cardiff,et al. Harvey-ras mediated neoplastic development in the mouse mammary gland. , 1989, Oncogene.
[141] R. Cardiff,et al. Isolation of a pathogenic clone of mouse mammary tumor virus , 1989, Journal of virology.
[142] R. Cardiff,et al. Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia. , 1988, Anticancer research.
[143] R. Cardiff,et al. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. , 1988, Oncogene.
[144] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[145] J. Ward,et al. Color Atlas of Neoplastic and Non-Neoplastic Lesions in Aging Mice , 1988 .
[146] D. Hanahan,et al. Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets , 1988, Cell.
[147] B. Groner,et al. Targeted c‐myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. , 1988, The EMBO journal.
[148] P. Leder,et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.
[149] B. Groner,et al. Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[150] Cori Bargmann,et al. The neu oncogene encodes an epidermal growth factor receptor-related protein , 1986, Nature.
[151] F. Talamantes,et al. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. , 1985, Endocrinology.
[152] P. Shubik. Progression and promotion. , 1984, Journal of the National Cancer Institute.
[153] R. Palmiter,et al. Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors , 1984, Cell.
[154] S. Aaronson,et al. Molecular cloning of integrated Gardner-Rasheed feline sarcoma virus: genetic structure of its cell-derived sequence differs from that of other tyrosine kinase-coding onc genes , 1983, Journal of virology.
[155] P. Leder,et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[156] B. Vennstrom,et al. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 , 1982, Journal of virology.
[157] T. Maloney,et al. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice. , 1981, Journal of the National Cancer Institute.
[158] R. Cardiff,et al. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules. , 1980, Cancer research.
[159] H. Varmus,et al. The vertebrate homolog of the putative transforming gene of avian myelocytomatosis virus: characteristics of the DNA locus and its RNA transcript. , 1980, Virology.
[160] G. Martin,et al. Teratocarcinomas and mammalian embryogenesis. , 1980, Science.
[161] J. Bishop,et al. DNA and RNA from Uninfected Vertebrate Cells Contain Nucleotide Sequences Related to the Putative Transforming Gene of Avian Myelocytomatosis Virus , 1979, Journal of virology.
[162] T. Dunn,et al. Classification of mouse mammary tumors in Dunn's miscellaneous group including recently reported types. , 1979, Journal of the National Cancer Institute.
[163] R. Cardiff,et al. Biology of breast preneoplasia , 1977, Cancer.
[164] B. Henderson,et al. Spontaneous tumors of aging wild house mice. Incidence, pathology, and C-type virus expression. , 1973, Journal of the National Cancer Institute.
[165] R. Huebner,et al. Feline sarcoma virus tumor induction in cats and dogs. , 1971, Journal of the American Veterinary Medical Association.
[166] R. Huebner,et al. Experimental Transmission of Feline Fibrosarcoma to Cats and Dogs , 1970, Nature.
[167] W. Kirsten,et al. Malignant lymphomas of extrathymic origin induced in rats by murine erythroblastosis virus. , 1969, Journal of the National Cancer Institute.
[168] G. Theilen,et al. Transmissible Feline Fibrosarcoma , 1969, Nature.
[169] L. Foulds,et al. The natural history of cancer. , 1958, Journal of chronic diseases.
[170] L. Foulds. Experimental study of the course and regulation of tumour growth. , 1951, Annals of the Royal College of Surgeons of England.
[171] K. Ulesko-Stroganowa. Die epithelialen Geschwülste der Mäuse. , 1913, Journal of Cancer Research and Clinical Oncology.
[172] R. Cardiff. The biology of mammary transgenes: Five rules , 2005, Journal of Mammary Gland Biology and Neoplasia.
[173] R. Cardiff,et al. The Comparative Pathology of Human and Mouse Mammary Glands , 2004, Journal of mammary gland biology and neoplasia.
[174] J. Pollard,et al. Macrophages: modulators of breast cancer progression. , 2004, Novartis Foundation symposium.
[175] R. Cardiff,et al. Signaling Exacerbates Mammary Gland Tumor Development Γ Ppar Material Supplemental , 2022 .
[176] K. Svenson,et al. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. , 1998, Experimental lung research.
[177] Furth Pa. SV40 rodent tumour models as paradigms of human disease: transgenic mouse models. , 1998 .
[178] R. Cardiff,et al. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. , 1994, Genes & development.
[179] R. Cardiff,et al. Transgenic mouse models of mammary tumorigenesis. , 1993, Cancer surveys.
[180] R. Cardiff,et al. Mammary Morphogenesis and Oncogenes , 1992 .
[181] R S Weinstein,et al. Telepathology. Long-distance diagnosis. , 1989, American journal of clinical pathology.
[182] R. Cardiff. Cellular and molecular aspects of neoplastic progression in the mammary gland. , 1988, European journal of cancer & clinical oncology.
[183] I. Verma,et al. The fos oncogene. , 1987, Advances in cancer research.
[184] R. Cardiff,et al. Mammary tumors in feral mice lacking MuMTV DNA. , 1985, Journal of experimental pathology.
[185] R. Cardiff. Protoneoplasia: the molecular biology of murine mammary hyperplasia. , 1984, Advances in cancer research.
[186] L. C. Stevens. Teratocarcinogenesis and spontaneous parthenogenesis in mice. , 1975, The ... Symposium. Society for Developmental Biology. Symposium.
[187] T. C. Jones,et al. ANIMAL MODELS OF HUMAN DISEASE , 2009 .
[188] P. Buckley,et al. A comparative study in vitro of a simian virus isolated from spontaneous woolly monkey fibrosarcoma and of a known feline fibrosarcoma virus. , 1973, Bibliotheca haematologica.
[189] P. Blair,et al. The mammary tumor virus (MTV). , 1968, Current topics in microbiology and immunology.
[190] S. Crawley,et al. Pathology, and , 2022 .